Skip to content
IXHLIncannex Healthcare Inc.

Earnings

When Incannex Healthcare Inc. reports, what it reported each quarter, and how the stock took the results.

14 quarters. Mar 31, 2023 to Sep 30, 2026. USD.

Next results · Q2 2027Projected

10-Q due Feb 10 – 17

No earnings release is on file for this company, so the day is the 10-Q’s, projected from its last 8 filings.

Quarter
Q2 2027 · Ends about Dec 31, 2026
10-Q window
Feb 10 – 17

Read against Q2 2026

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Revenue, change from a year earlier: Q1 2027 n/m, Q1 2026 −100.0%, Q4 2025 n/m, Q3 2025 n/m
Net income
-$6.52M
Net income, change from a year earlier: Q1 2027 n/m, Q4 2026 n/m, Q3 2026 n/m, Q2 2026 n/m
EPS
-$0.02
EPS, change from a year earlier: Q1 2027 n/m, Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m

Quarter by quarter

Q1 2027$0.00No Q1 2026 on file

Latest results

  1. Q1 2027Nov 12, 2026, before the open+3.0%by the close of Nov 12
    Revenue
    $0.00
    —
    Net income
    -$1.94M
    N/M
    EPS
    -$0.15
    N/M
  2. Q4 2026Sep 25, 2026, before the open2.6%by the close of Sep 25
    Revenue
    —
    —
    Net income
    -$2.49M
    N/M
    EPS
    —
    —
  3. Q3 2026May 15, 2026, before the open+2.1%by the close of May 15
    Revenue
    —
    —
    Net income
    -$3.88M
    N/M
    EPS
    -$0.35
    N/M
  4. Q2 2026Feb 13, 2026, before the open0.7%by the close of Feb 13
    Revenue
    —
    —
    Net income
    -$6.52M
    N/M
    EPS
    -$0.02
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2027
Q1 2027Sep 30, 2026—Nov 12, 202643 d10-Q$0.00—-$0.15+3.0%
FY 2026
Q4 2026derivedJun 30, 2026—Sep 25, 202687 d10-K———2.6%
Q3 2026Mar 31, 2026—May 15, 202645 d10-Q——-$0.35+2.1%
Q2 2026Dec 31, 2025—Feb 13, 202644 d10-Q——-$0.020.7%
Q1 2026Sep 30, 2025—Nov 14, 202545 d10-Q$0.00−100.0%-$0.622.8%
FY 2025
Q4 2025derivedJun 30, 2025—Sep 29, 202591 d10-K$0.00——11.9%
Q3 2025Mar 31, 2025—May 15, 202545 d10-Q$0.00—-$6.1961.4%
Q2 2025Dec 31, 2024—Feb 14, 202545 d10-Q$12.00K—-$0.331.1%
Q1 2025Sep 30, 2024—Nov 14, 202445 d10-Q$74.00K—-$0.2914.5%
Earlier years, FY 2023 to FY 2024

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 12, 2026073147
10-KSep 25, 2026063506
10-QMay 15, 2026057227
10-QFeb 13, 2026015867
10-QNov 14, 2025110299
10-KSep 29, 2025092837
10-QMay 15, 2025043682
10-QFeb 14, 2025013783
10-QNov 14, 2024098421
10-KSep 30, 2024082937

Provenance

ProvenanceData status and checks

Incannex Healthcare Inc. · CIK 1873875 · Engraved from SEC EDGAR